Illumina to divest cancer test maker Grail after antitrust battles
(Reuters) – Gene sequencing company Illumina (NASDAQ:ILMN) said on Sunday it will divest cancer diagnostic test maker Grail after the…
(Reuters) – Gene sequencing company Illumina (NASDAQ:ILMN) said on Sunday it will divest cancer diagnostic test maker Grail after the…
A look at the day ahead in European and global markets from Wayne Cole. It’s been a subdued start to…
(Reuters) – BlackRock has agreed to invest up to $400 million in Dubai-based decarbonisation company Positive Zero through a diversified…
Apple (NASDAQ:AAPL) shares fell 0.8% in pre-market Monday after Bloomberg News reported that various Chinese government agencies and state-backed companies…
(Reuters) – Citigroup Inc (NYSE:C)’s plan to set up a wholly-owned securities business in China is taking longer than expected…
(Reuters) – Supermarkets in the UK and Europe are offering more own-brand festive food from roast duck to truffle crackers…
(Reuters) – IBM said on Monday that it would buy Software AG’s enterprise integration platforms for 2.13 billion euros ($2.33…
(Reuters) – Global equities long/short hedge funds’ bets against U.S. stocks got squeezed in the last two days after U.S.…
(Reuters) – Consumer goods giant Unilever (LON:ULVR) on Monday said it would sell Elida Beauty, its non-core beauty and personal…
Alphabet (NASDAQ:GOOGL) Inc., the parent company of the internet colossus Google, stands as a testament to the transformative power of…